However, studies in other types of cancer have shown that CCR3 plays a major role in promoting tumor progression and is strongly associated with poor prognosis of patients, with its role in the TIME exhibited through the recruitment of TAMs to facilitate tumor progression (5, 28–30). This evidence concerns the gene CCR3 and neoplasm.